[ad_1]
Can AMD deliver on bullish AI-revenue expectations next year? Some — but not all — feel more confident after earnings.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...